Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

• Sellam, J
• Rivière, E
• Courties, A
• Rouzaire, P-O
• Tolusso, B
• Vital, EM
• Emery, P
• Ferraccioli, G
• Soubrier, M
• Ly, B
• Hendel Chavez, H
• Taoufik, Y
• Dougados, M
• Mariette, X

(c) 2017, the Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

• Accepted: 6 January 2017
• Published (online): 23 January 2017
• Published: 23 January 2017